EHR and practice management has matured into one of the more institutionally underwritten parts of healthcare technology. Vertical SaaS investors and growth funds now price specialty EHR, RCM and clearinghouse businesses on durable per-provider economics, with little tolerance for unfunded implementation backlogs or RCM lines that compress gross margin. The hospital tier is effectively closed to new entrants, so credible rounds concentrate around behavioural, dental, post-acute, optometry, PT and ambulatory specialty platforms.

The relevant investor mix runs across healthcare-focused funds like General Catalyst Health, F-Prime, 7wireVentures and Oxeon that lead specialty EHR and RCM rounds, the vertical SaaS growth funds that have backed Tebra and similar operators, and the payer and benefits-aligned CVCs - Optum Ventures, CVS Health Ventures and BlueCross BlueShield Venture Partners - that engage where the platform integrates with claims and benefits infrastructure. Flow has direct relationships across this set and targets funds with a recent lead in the same care setting rather than running a generic healthcare IT list.

Flow has experience running VC fundraising processes for EHR and practice management companies across specialty ambulatory EHR vendors, behavioural and dental practice platforms, post-acute and long-term care systems, RCM-led operators and clearinghouse and claims infrastructure. Our extensive investor network spans early-stage seed funds, growth-stage investors, and strategic and corporate VC arms.